Analytical Data
-
Gene name
AHNAK2
- Application
-
Alternative Names
AHNAK2; C14orf78; KIAA2019Protein AHNAK2
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IVF2
-
Expression Region
1-483aa
-
AA Sequence
MRLPETQVLPGEIDETPLSKPGHDLASMEDKTEKWSSQPEGPLKLKASSTDMPSQISVVNVDQLWEDSVLTVKFPKLMVPRFSFAAPSSEDDVFIPTVREVQCPEANIDTALCKESPGLWGASILKAGAGVPGEQPVDLNLPLEAPPISKVRVHIQGAQVESQEVTIHSIVTPEFVDLSVPRTFSTQIVRESEIPTSEIQTPSYGFSLLKVKIPEPHTQARVYTTMTQHSRTQEGTEEAPIQATPGVDSISGDLQPDTGEPFEMISSSVNVLGQQTLTFEVPSGHQLADSCSDEEPAEILEFPPDDSQEATTPLADEGRAPKDKPESKKSGLLWFWLPNIGFSSSVDETGVDSKNDVQRSAPIQTQPEARPEAELPKKQEKAGWFRFPKLGFSSSPTKKSKSTEDGAELEEQKLQEETITFFDARESFSPEEKEEGELIGPVGTGLDSRVMVTSAARTELILPEQDRKADDESKGSGLGPNEG
-
Molecular Weight
79.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AHNAK2 is a large cytoskeletal protein that has garnered interest due to its involvement in various cellular processes, including cell adhesion, migration, and signal transduction. Its expression has been observed in multiple tissues, suggesting a potential role in tissue development and homeostasis. Recent studies have indicated that AHNAK2 may be linked to several pathological conditions, including cancer, where it could play a role in tumor growth and metastasis. The understanding of AHNAK2's functions and mechanisms has been hindered by the lack of a comprehensive analysis of its structural properties and interactions with other cellular components. Thus, the recombinant expression of AHNAK2 is crucial for elucidating its biological roles and pathways. By producing AHNAK2 in a recombinant system, researchers can obtain a pure form of the protein for biochemical and structural studies. These investigations could provide insights into the protein's functional domains, potential post-translational modifications, and interactions with other molecules, enhancing our understanding of its contribution to cellular dynamics and dysfunctions in disease states. Overall, studying the recombinant AHNAK2 protein represents a significant step towards deciphering its roles in health and disease, which could eventually lead to the development of novel therapeutic strategies targeting AHNAK2-related pathways.
